Welch Reappointed to Committee on Oversight and Reform; Prescription Drug Pricing a Major Committee Focus in New Congress
WASHINGTON - Rep. Peter Welch (D-Vt.) has been reappointed to the House Committee on Oversight and Reform. The committee has broad jurisdiction over executive branch programs and activities. Welch has served on the committee since he was first elected to Congress in 2006.
A top priority for Welch and Committee Chairman Elijah Cummings (D-Md.) in the new Congress is investigating the broken prescription drug pricing market that has led to skyrocketing drug prices for consumers, businesses and taxpayers. Welch is one of the leading advocates in the House on drug pricing reforms. He has partnered with Chairman Cummings on legislation to cut drug prices by requiring the federal government to use its immense purchasing power in the Medicare program to negotiate lower drug prices for seniors and taxpayers. In March 2017, Welch and Cummings met with President Trump on the issue.
The appointment of Welch to the Oversight and Reform Committee rounds out his committee and leadership assignments in the 116th Congress.